- Home
- CELU vs TORO Comparison
CELU vs TORO Comparison
Compare CELU & TORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- TORO
- Stock Information
- Founded
- CELU 2016
- TORO 2022
- Country
- CELU United States
- TORO Cyprus
- Employees
- CELU N/A
- TORO N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- TORO Marine Transportation
- Sector
- CELU Health Care
- TORO Consumer Discretionary
- Exchange
- CELU Nasdaq
- TORO Nasdaq
- Market Cap
- CELU 42.2M
- TORO 45.1M
- IPO Year
- CELU N/A
- TORO N/A
- Fundamental
- Price
- CELU $1.61
- TORO $1.95
- Analyst Decision
- CELU
- TORO
- Analyst Count
- CELU 0
- TORO 0
- Target Price
- CELU N/A
- TORO N/A
- AVG Volume (30 Days)
- CELU 54.8K
- TORO 64.3K
- Earning Date
- CELU 12-06-2024
- TORO 04-15-2025
- Dividend Yield
- CELU N/A
- TORO N/A
- EPS Growth
- CELU N/A
- TORO N/A
- EPS
- CELU N/A
- TORO 1.09
- Revenue
- CELU $48,200,000.00
- TORO $22,394,283.00
- Revenue This Year
- CELU N/A
- TORO N/A
- Revenue Next Year
- CELU $233.89
- TORO N/A
- P/E Ratio
- CELU N/A
- TORO $1.75
- Revenue Growth
- CELU 225.94
- TORO 0.40
- 52 Week Low
- CELU $1.00
- TORO $1.70
- 52 Week High
- CELU $5.22
- TORO $4.85
- Technical
- Relative Strength Index (RSI)
- CELU 49.49
- TORO 41.22
- Support Level
- CELU $1.47
- TORO $1.79
- Resistance Level
- CELU $1.77
- TORO $2.02
- Average True Range (ATR)
- CELU 0.16
- TORO 0.23
- MACD
- CELU 0.01
- TORO -0.01
- Stochastic Oscillator
- CELU 63.04
- TORO 27.66
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.